JANX
Janux Therapeutics Inc
16.50$
-5.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -1,149.7% | -466.8% | -498.4% | -625.7% | -413.8% | -822.3% | |
| – | 3.4% | 3.1% | 9.8% | 24.2% | 19.5% | 20.3% | |
| – | 18.9% | 190.0% | 199.8% | 247.5% | 311.9% | 402.2% | |
| – | 529.7% | 185.3% | 199.8% | – | – | – | |
| – | 102.4% | 243.1% | 49.7% | -81.1% | 6.5% | 67.1% | |
| – | 390.0% | 40.7% | 74.8% | 22.9% | 3.4% | 10.4% | |
| – | -89,727.1% | -9,374.8% | 676.6% | -509.6% | -2,436.9% | -3,009.8% | |
| – | – | 5,613.6% | – | – | – | -3.5% | |
| – | 657.9% | 4,964.2% | 272.0% | – | – | – | |
| – | 3,032.6% | 10,627.6% | 5.8% | 736.7% | 6,736.3% | 49.5% | |
| – | 1,882.9% | 785.9% | 184.0% | -398.6% | 3,885.5% | -3,782.7% | |
| – | -1,149.7% | -507.5% | -573.2% | -648.6% | -417.2% | -832.8% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.